STRATA™ measures the contextual support environment of patients. The social and practical forces that stabilize or destabilize adherence behavior. While BASE™ captures predictive behavioral stability and MVMT™ captures recent adherence patterns, STRATA completes the triad by illuminating the external relational and environmental factors that influence adherence outcomes.
Medication adherence is not solely a product of personal intention or habit. Patients operate within social networks, logistical constraints, and resource landscapes that either reinforce or undermine their adherence routines. STRATA provides a structured, patient-reported view of that environment, offering insight into areas that may support or compromise medication-taking behavior.
As the third pillar in the Cartographic Behavioral Framework, STRATA ensures that adherence is understood not just as a behavior, but as a product of the interaction between individual capacity, recent behavior, and relational context.
Conceptual Importance
STRATA recognizes that:
By combining STRATA with BASE and MVMT, Adherence Cartography captures the complete adherence ecosystem, creating a detailed map of stability, fragility, and actionable risk.
STRATA™ Domains & Assessment
Each item is scored to reflect supportive versus fragile context. Higher scores indicate stronger relational and resource support; lower scores indicate vulnerability that may compromise adherence even when BASE and MVMT are strong.
STRATA enables:
Together, these three instruments provide a comprehensive map of adherence, showing not just whether patients take their medications, but how personal capacity, recent behavior, and relational context interact to create stability or fragility.
STRATA™ is the intellectual property of Philip Morisky and is exclusively distributed through Adherence Cartography. Unauthorized use, reproduction, or distribution is strictly prohibited.
Disclaimer on Use of the BASE Instrument
BASE™ (Behavioral Architecture & Stability Evaluation) is an exploratory, hypothesis-generating research instrument. It is not a validated clinical tool and should not be used as the sole basis for diagnosis, treatment decisions, or patient care planning.
Preliminary research has shown promising insights into its potential utility, but additional validation studies are required to establish its reliability, validity, and clinical applicability. Any use of BASE at this stage should be considered investigational and for research purposes only.
Copyright © 2023 Adherence. All Rights Reserved.
Adherence Cartography™, Behavioral Stability Assessment (BSA™,), Behavioral Adherence Score (BAS™), and Behavioral Stability Index (BSI™) are trademarks of Adherence Cartography.
MMAS®, MMAS-4™, MMAS-8™, Morisky Medication Adherence Scale™, and Morisky Scale™ are registered trademarks or trademarks owned by Dr. Donald E. Morisky.
health tech, digital health, telehealth, healthcare innovation, medical technology, ehealth, health informatics, remote patient monitoring, mhealth, telemedicine, patient engagement, wearable health devices, health app, ai in healthcare, telehealth solutions, virtual care, health tech startups, connected health, population health management, healthcare analytics, personalized medicine
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Join us in advancing a national movement toward cartographic behavioral science and precision-guided adherence care.
Your support helps bring the BASE™, MVMT™, and STRATA™ frameworks to Bhutan’s health system in partnership with the Ministry of Health. Together, we are building the foundation for a behaviorally intelligent health infrastructure, equipping clinicians and policymakers to map, measure, and strengthen real-world treatment stability.
Your contribution directly advances evidence-based care, empowering Bhutan to lead in the next generation of global adherence innovation.
[Donate Now]